PAPER Stoccoro A, Coppedè F

Exposure to Metals, Pesticides, and Air Pollutants: Focus on Resulting DNA Methylation Changes in Neurodegenerative Diseases.

Biomolecules. 2024 Oct 27;14(11) PubMed.

PAPER Cardona F

Special Issue "Mechanisms and Novel Therapeutic Approaches for Neurodegenerative Diseases".

Biomedicines. 2024 Nov 8;12(11) PubMed.

PAPER Clarke BE, Ziff OJ, Tyzack G, Howe MP, Wang Y, Klein P, Smith CA, Hall CA, Helmy A, Howell M, Kelly G, Patani R

Human VCP mutant ALS/FTD microglia display immune and lysosomal phenotypes independently of GPNMB.

Mol Neurodegener. 2024 Nov 26;19(1):90. PubMed.

PAPER Dash BP, Freischmidt A, Helferich AM, Ludolph AC, Andersen PM, Weishaupt JH, Hermann A

Upregulated miR-10b-5p as a potential miRNA signature in amyotrophic lateral sclerosis patients.

Front Cell Neurosci. 2024;18:1457704. Epub 2024 Nov 7 PubMed.

PAPER Kokona B, Cunningham NR, Quinn JM, Jacobsen DR, Garcia FJ, Galindo SM, Petrucelli L, Stafford WF, Laue TM, Fairman R

Studying C9orf72 dipeptide repeat polypeptide aggregation using an analytical ultracentrifuge equipped with fluorescence detection.

Anal Biochem. 2025 Feb;697:115720. Epub 2024 Nov 22 PubMed.

PAPER Carracedo S, Launay A, Dechelle-Marquet PA, Faivre E, Blum D, Delarasse C, Boué-Grabot E

Purinergic-associated immune responses in neurodegenerative diseases.

Prog Neurobiol. 2024 Dec;243:102693. Epub 2024 Nov 22 PubMed.

PAPER Li Z, Zhang Y, Li D, Du X, Chen L, Guo Y

Microglial upregulation of CD109 expression in spinal cord of amyotrophic lateral sclerosis mouse model and its role in modulating inflammation and TGFβ/SMAD pathway.

Neuroscience. 2025 Jan 9;564:202-213. Epub 2024 Nov 21 PubMed.

PAPER Alfahel L, Rajkovic A, Israelson A

Protocol for handling and using SOD1 mice for amyotrophic lateral sclerosis pre-clinical studies.

STAR Protoc. 2024 Dec 20;5(4):103459. Epub 2024 Nov 22 PubMed.

PAPER Miller EC, Conley P, Alirezaei M, Wolfova K, Gonzales MM, Tan ZS, Tom SE, Yee LM, Brickman AM, Bello NA

Associations between adverse pregnancy outcomes and cognitive impairment and dementia: a systematic review and meta-analysis.

Lancet Healthy Longev. 2024 Dec;5(12):100660. Epub 2024 Dec 12 PubMed.

PAPER Mekala S, Wu Y, Li YM

Strategies of positron emission tomography (PET) tracer development for imaging of tau and α-synuclein in neurodegenerative disorders.

RSC Med Chem. 2024 Nov 20; Epub 2024 Nov 20 PubMed.

PAPER Tascedda S, Sarti P, Rivi V, Guerrera CS, Platania GA, Santagati M, Caraci F, Blom JM

Advanced AI techniques for classifying Alzheimer's disease and mild cognitive impairment.

Front Aging Neurosci. 2024;16:1488050. Epub 2024 Nov 29 PubMed.

PAPER Zhu F, Yin S, Wang Y, Zhong Y, Ji Q, Wu J

Effects of Probiotics on Neurodegenerative Disease-Related Symptoms and Systemic Inflammation: A Systematic Review.

Int J Gen Med. 2024;17:5941-5958. Epub 2024 Dec 10 PubMed.

PAPER Wyman-Chick KA, Barrett MJ, Miller MJ, Sargent L, Chrenka EA, Kane JP, Crowley SJ, Kuntz JL, Parashos SA, Schousboe JT, Nguyen H, Werner AM, Rossom RC

The relationship between anticholinergic burden and frailty in the year preceding a diagnosis of dementia with Lewy bodies.

Alzheimers Dement (Amst). 2024;16(4):e70034. Epub 2024 Dec 14 PubMed.

PAPER Cohen JS, Phillips J, Das SR, Olm CA, Radhakrishnan H, Rhodes E, Cousins KA, Xie SX, Nasrallah IM, Yushkevich PA, Wolk DA, Lee EB, Weintraub D, Irwin DJ, McMillan CT

Posterior hippocampal sparing in Lewy body disorders with Alzheimer's copathology: An in vivo MRI study.

Neuroimage Clin. 2024 Dec 7;45:103714. Epub 2024 Dec 7 PubMed.

PAPER Travaglia A, Lal S, Pullagura SR

Advancing ALS research: public-private partnerships to accelerate drug and biomarker development.

Trends Neurosci. 2025 Jan;48(1):1-2. Epub 2024 Nov 21 PubMed.